Steroid injection during stroke clot removal surgery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether injecting a steroid (methylprednisolone) directly into brain blood vessels after removing a stroke clot helps reduce brain swelling and improve recovery. You would be eligible if you had a large clot stroke in the front part of your brain that was successfully removed within the past 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Stroke caused by a large blood clot in the front of the brain, confirmed by imaging (CT, MRI, or angiography)
- Successfully had the clot removed by endovascular thrombectomy (a minimally invasive surgery)
- Stroke severity score (NIHSS) of 6 or higher
- No active bleeding in the brain on imaging
- Able to sign consent and complete follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
This trial tests whether adding a steroid medicine (methylprednisolone) to the standard procedure to remove a blood clot (thrombectomy) can improve recovery in people with large, severe strokes. The study aims to see if the steroid helps reduce brain swelling and improves outcomes.
This trial tests whether adding a steroid (methylprednisolone) to the standard clot-removal procedure can improve recovery in people with a severe, large stroke. It aims to reduce brain swelling and improve outcomes after the procedure.
This trial tests if the steroid methylprednisolone helps people who have had a major stroke and also have low infection-fighting white blood cells (lymphocytes). It is for patients who are getting a procedure to remove the clot (thrombectomy) within 24 hours of the stroke.
This trial tests whether adding a steroid called methylprednisolone during a procedure to place a stent for an unruptured brain aneurysm can reduce side effects and improve recovery. It's a phase 4 study, meaning the drug is already approved for other uses, and researchers are checking if it works well for this specific situation.
Hear when a new Ischemia Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.